ATXI Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-16 | Fortress Biotech, Inc. | 10 percent owner | 3,547,393 | A-Award | A | 413,507 | 0.00 | 0.00 |
| 2024-01-02 | Fortress Biotech, Inc. | 10 percent owner | 3,133,886 | A-Award | A | 2,101,496 | 0.00 | 0.00 |
| 2023-12-11 | Davidow Robert L | 10 percent owner | 681,000 | S-Sale | D | 264,000 | 0.14 | 36,960.00 |
| 2023-12-11 | Davidow Robert L | 10 percent owner | 215,800 | S-Sale | D | 126,000 | 0.14 | 17,640.00 |
| 2023-12-11 | Davidow Robert L | 10 percent owner | 147,000 | S-Sale | D | 128,000 | 0.14 | 17,920.00 |
| 2023-12-11 | Davidow Robert L | 10 percent owner | 80,000 | S-Sale | D | 20,000 | 0.14 | 2,800.00 |
| 2023-12-11 | Davidow Robert L | 10 percent owner | 74,000 | S-Sale | D | 61,000 | 0.14 | 8,540.00 |
| 2023-12-11 | Davidow Robert L | 10 percent owner | 22,000 | S-Sale | D | 18,000 | 0.15 | 2,700.00 |
| 2023-10-31 | Davidow Robert L | 10 percent owner | 945,000 | D | 0 | 0.00 | 0.00 | |
| 2023-10-31 | Davidow Robert L | 10 percent owner | 341,800 | I | 0 | 0.00 | 0.00 | |
| 2023-10-31 | Davidow Robert L | 10 percent owner | 275,000 | I | 0 | 0.00 | 0.00 | |
| 2023-10-31 | Davidow Robert L | 10 percent owner | 135,000 | I | 0 | 0.00 | 0.00 | |
| 2023-10-31 | Davidow Robert L | 10 percent owner | 100,000 | I | 0 | 0.00 | 0.00 | |
| 2023-10-31 | Davidow Robert L | 10 percent owner | 90,000 | I | 0 | 0.00 | 0.00 | |
| 2023-10-31 | Davidow Robert L | 10 percent owner | 40,000 | I | 0 | 0.00 | 0.00 | |
| 2023-09-08 | ROSENWALD LINDSAY A MD | director | 354,318 | P-Purchase | A | 348,675 | 0.72 | 251,046.00 |
| 2023-09-08 | Fortress Biotech, Inc. | 10 percent owner | 1,032,390 | P-Purchase | A | 418,410 | 0.72 | 301,255.00 |
| 2023-06-30 | Charles Faith L. | director | 100,000 | A-Award | A | 100,000 | 1.14 | 114,000.00 |
| 2023-06-30 | Jin David | officer: Interim PFO and COO | 250,000 | A-Award | A | 250,000 | 1.14 | 285,000.00 |
| 2023-06-30 | ROSENWALD LINDSAY A MD | director | 100,000 | A-Award | A | 100,000 | 1.14 | 114,000.00 |
| 2023-06-30 | KRANZLER JAY D | director | 100,000 | A-Award | A | 100,000 | 1.14 | 114,000.00 |
| 2023-06-30 | Oltmans Curtis Gale | director | 100,000 | A-Award | A | 100,000 | 1.14 | 114,000.00 |
| 2023-06-30 | Herskowitz Neil | director | 100,000 | A-Award | A | 100,000 | 1.14 | 114,000.00 |
| 2023-06-29 | MacLean Alexandra | director, officer: Chief Executive Officer | 800,000 | A-Award | A | 800,000 | 1.14 | 912,000.00 |
| 2023-03-31 | Fortress Biotech, Inc. | 10 percent owner | 613,980 | A-Award | A | 52,419 | 0.00 | 0.00 |
| 2023-01-03 | Fortress Biotech, Inc. | director | 561,561 | A-Award | A | 231,316 | 0.00 | 0.00 |
| 2022-12-31 | Fortress Biotech, Inc. | director | 330,245 | A-Award | A | 90,909 | 0.00 | 0.00 |
| 2022-10-11 | InvaGen Pharmaceuticals, Inc. | director | 0 | S-Sale | D | 388,888 | 7.71 | 2,999,882.00 |
| 2022-08-01 | MacLean Alexandra | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-05-11 | Jin David | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-05-16 | Charles Faith L. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-12-17 | KRANZLER JAY D | director | 133,683 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2021-12-17 | KRANZLER JAY D | director | 113,683 | A-Award | A | 49,020 | 0.00 | 0.00 |
| 2021-12-17 | Herskowitz Neil | director | 183,744 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2021-12-17 | Herskowitz Neil | director | 163,744 | A-Award | A | 49,020 | 0.00 | 0.00 |
| 2021-12-17 | Oltmans Curtis Gale | director | 49,020 | A-Award | A | 49,020 | 0.00 | 0.00 |
| 2021-04-01 | Oltmans Curtis Gale | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-12-17 | Lu Lucy | director, officer: President, CEO | 748,949 | A-Award | A | 411,616 | 0.00 | 0.00 |
| 2021-12-17 | Vazzano Joseph Walter | officer: Chief Financial Officer | 165,757 | A-Award | A | 100,505 | 0.00 | 0.00 |
| 2021-09-15 | Vazzano Joseph Walter | officer: Chief Financial Officer | 65,252 | S-Sale | D | 7,160 | 1.62 | 11,599.00 |
| 2021-05-06 | Herskowitz Neil | director | 134,724 | P-Purchase | A | 2,500 | 3.99 | 9,975.00 |
| 2020-08-20 | Vazzano Joseph Walter | officer: Chief Financial Officer | 57,412 | S-Sale | D | 3,840 | 12.13 | 46,579.00 |
| 2020-06-16 | KRANZLER JAY D | director | 84,663 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2020-06-16 | Herskowitz Neil | director | 132,224 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2020-03-10 | Vazzano Joseph Walter | officer: Chief Financial Officer | 61,252 | P-Purchase | A | 1,889 | 7.94 | 14,999.00 |
| 2020-03-09 | Vazzano Joseph Walter | officer: Chief Financial Officer | 59,363 | P-Purchase | A | 100 | 7.97 | 797.00 |
| 2020-03-09 | Vazzano Joseph Walter | officer: Chief Financial Officer | 59,263 | P-Purchase | A | 1,400 | 7.99 | 11,186.00 |
| 2020-02-27 | Herskowitz Neil | director | 122,224 | P-Purchase | A | 2,400 | 8.20 | 19,680.00 |
| 2020-02-26 | Herskowitz Neil | director | 119,824 | P-Purchase | A | 161 | 8.73 | 1,406.00 |
| 2020-02-25 | Vazzano Joseph Walter | officer: Chief Financial Officer | 57,863 | P-Purchase | A | 1,200 | 9.09 | 10,908.00 |
| 2020-02-25 | Herskowitz Neil | director | 119,663 | P-Purchase | A | 10,000 | 9.31 | 93,100.00 |
| 2020-02-12 | Vazzano Joseph Walter | officer: Chief Financial Officer | 50,505 | A-Award | A | 22,727 | 0.00 | 0.00 |
| 2020-02-12 | Lu Lucy | director, officer: President, CEO | 246,576 | A-Award | A | 110,959 | 0.00 | 0.00 |
| 2019-02-08 | InvaGen Pharmaceuticals, Inc. | 5,833,333 | D | 0 | 0.00 | 0.00 | ||
| 2019-02-08 | InvaGen Pharmaceuticals, Inc. | 3,923,429 | I | 0 | 0.00 | 0.00 | ||
| 2019-02-08 | InvaGen Pharmaceuticals, Inc. | 250,000 | I | 0 | 0.00 | 0.00 | ||
| 2019-02-08 | InvaGen Pharmaceuticals, Inc. | 0 | I | 135,617 | 0.00 | 0.00 | ||
| 2019-09-12 | Ingram Elizabeth Garrett | director | 16,000 | P-Purchase | A | 16,000 | 6.27 | 100,320.00 |
| 2019-08-27 | KRANZLER JAY D | director | 74,663 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2019-08-27 | Herskowitz Neil | director | 109,663 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2019-08-08 | Vazzano Joseph Walter | officer: Chief Financial Officer | 59,038 | S-Sale | D | 2,313 | 5.62 | 12,999.00 |
| 2019-08-09 | Vazzano Joseph Walter | officer: Chief Financial Officer | 56,663 | S-Sale | D | 2,375 | 5.56 | 13,205.00 |
| 2019-08-01 | Ingram Elizabeth Garrett | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-06-18 | Herskowitz Neil | director | 99,663 | P-Purchase | A | 2,000 | 5.83 | 11,660.00 |
| 2019-06-17 | Herskowitz Neil | director | 97,663 | P-Purchase | A | 3,000 | 5.88 | 17,640.00 |
| 2019-06-03 | Vazzano Joseph Walter | officer: Chief Financial Officer | 27,778 | A-Award | A | 27,778 | 0.00 | 0.00 |
| 2019-06-03 | Lu Lucy | director, officer: President, CEO | 135,617 | A-Award | A | 135,617 | 0.00 | 0.00 |
| 2019-04-30 | Moore Thomas Gregory | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-04-15 | Herskowitz Neil | director | 94,663 | P-Purchase | A | 1,000 | 4.52 | 4,520.00 |
| 2019-03-29 | Herskowitz Neil | director | 93,663 | P-Purchase | A | 1,400 | 5.11 | 7,154.00 |
| 2019-03-28 | Herskowitz Neil | director | 92,263 | P-Purchase | A | 600 | 5.11 | 3,066.00 |
| 2019-02-25 | Herskowitz Neil | director | 91,663 | P-Purchase | A | 5,000 | 5.46 | 27,300.00 |
| 2019-02-08 | Gogtay Jaideep Ashok | 0 | 0 | 0.00 | 0.00 | |||
| 2019-02-08 | Saxena Nishant | 0 | 0 | 0.00 | 0.00 | |||
| 2019-02-05 | Herskowitz Neil | director | 86,663 | P-Purchase | A | 1,850 | 5.77 | 10,674.00 |
| 2019-02-04 | Herskowitz Neil | director | 84,813 | P-Purchase | A | 7,000 | 5.91 | 41,370.00 |
| 2019-01-30 | Herskowitz Neil | director | 77,813 | P-Purchase | A | 650 | 5.91 | 3,842.00 |
| 2019-01-29 | Herskowitz Neil | director | 77,163 | P-Purchase | A | 8,553 | 5.91 | 50,548.00 |
| 2019-01-28 | Herskowitz Neil | director | 68,610 | P-Purchase | A | 1,447 | 5.84 | 8,450.00 |
| 2018-12-10 | Paley Jeffrey | director | 79,663 | P-Purchase | A | 5,000 | 4.76 | 23,800.00 |
| 2018-12-03 | Paley Jeffrey | director | 74,663 | P-Purchase | A | 10,000 | 5.48 | 54,754.00 |
| 2018-08-07 | Vazzano Joseph Walter | officer: VP Finance & Corp. Controller | 61,351 | G-Gift | A | 30,000 | 0.00 | 0.00 |
| 2018-08-07 | Lu Lucy | director, officer: President, CEO | 807,333 | G-Gift | A | 250,000 | 0.00 | 0.00 |
| 2018-08-07 | ROSENWALD LINDSAY A MD | director | 84,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | Herskowitz Neil | director | 67,163 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | KRANZLER JAY D | director | 64,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | Reines Scott | officer: Interim Chief Medical Officer | 45,000 | G-Gift | A | 10,000 | 0.00 | 0.00 |
| 2018-08-07 | WEISS MICHAEL S | director | 24,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | Paley Jeffrey | director | 64,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | SAMAD AKHTAR | director | 64,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-06-28 | Vazzano Joseph Walter | officer: VP Finance & Corp. Controller | 31,351 | A-Award | A | 1,351 | 3.66 | 4,945.00 |
| 2018-06-14 | Lu Lucy | director, officer: President, CEO | 557,333 | A-Award | A | 5,000 | 4.00 | 20,000.00 |
| 2018-06-08 | ROSENWALD LINDSAY A MD | director | 70,000 | P-Purchase | A | 5,234 | 4.34 | 22,727.00 |
| 2018-06-07 | ROSENWALD LINDSAY A MD | director | 64,766 | P-Purchase | A | 14,800 | 4.32 | 63,969.00 |
| 2018-06-06 | ROSENWALD LINDSAY A MD | director | 49,966 | P-Purchase | A | 9,100 | 4.35 | 39,576.00 |
| 2018-06-05 | ROSENWALD LINDSAY A MD | director | 40,866 | P-Purchase | A | 8,400 | 4.28 | 35,949.00 |
| 2018-06-04 | ROSENWALD LINDSAY A MD | director | 32,466 | P-Purchase | A | 3,800 | 4.19 | 15,921.00 |
| 2018-06-01 | ROSENWALD LINDSAY A MD | director | 28,666 | P-Purchase | A | 8,666 | 4.15 | 36,003.00 |
| 2018-06-08 | ROSENWALD LINDSAY A MD | director | 25,234 | P-Purchase | A | 5,234 | 4.34 | 22,716.00 |
| 2018-04-25 | Herskowitz Neil | director | 52,500 | P-Purchase | A | 1,000 | 3.80 | 3,800.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
